NSD2 and mantle cell lymphoma: Like NSD2, mutations in the SET domain of NSD3 (E1181K and T1232A), which counteract the auto-inhibition mechanism of H3K36 methylation, are associated with mantle cell lymphoma and chronic lymphocytic leukemia [118, 119].